{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-035624","form_type":"8-K","ticker":"ATXI","cik":"0001644963","company_name":"AVENUE THERAPEUTICS, INC.","filed_at":"2025-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.028633+00:00","generated_at":"2026-05-16T18:48:19.843128+00:00","sec_items":["5.08","8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"confidence":"high","headline":"Avenue Therapeutics sets Dec 30, 2025 annual meeting; Nov 28 deadline for proposals","bullets":["Annual meeting scheduled for December 30, 2025; proxy statement to be filed with SEC.","Shareholder proposals for proxy inclusion under Rule 14a-8 must be received by November 28, 2025.","Director nominations and other non-14a-8 proposals also due by November 28, 2025.","All proposals must be submitted in writing to Corporate Secretary at Bay Harbor Islands address."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-035624","json":"https://secwatch.observer/filing/0001437749-25-035624.json","markdown":"https://secwatch.observer/filing/0001437749-25-035624.md","text":"https://secwatch.observer/filing/0001437749-25-035624.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1644963/000143774925035624/0001437749-25-035624-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1644963/000143774925035624/atxi20251118c_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T18:48:19.843128+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}